Equities

Qingdao NovelBeam Technology Co Ltd

688677:SHH

Qingdao NovelBeam Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)25.73
  • Today's Change-13.41 / -34.26%
  • Shares traded1.87m
  • 1 Year change-55.71%
  • Beta0.6165
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Qingdao NovelBeam Technology Co Ltd's net income fell -20.19% from 182.57m to 145.71m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 12.61% to 14.75%.
Gross margin63.85%
Net profit margin29.73%
Operating margin33.24%
Return on assets8.81%
Return on equity9.77%
Return on investment9.37%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Qingdao NovelBeam Technology Co Ltd fell by 43.84m. However, the company earned 158.12m from its operations for a Cash Flow Margin of 33.60%. In addition the company used 92.67m on investing activities and also paid 110.19m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share10.63
Tangible book value per share10.38
More ▼

Balance sheet in CNYView more

Qingdao NovelBeam Technology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio11.66
Quick ratio9.12
Total debt/total equity0.0268
Total debt/total capital0.0262
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -3.75% and -19.96%, respectively. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)53.11%
EPS growth(5 years)16.43
EPS (TTM) vs
TTM 1 year ago
-21.54
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.